Emergent BioSolutions Inc.

EBS Stock Healthcare Biotechnology
$5.91
-0.03 (-0.51%)
Price as of Aug 28, 2026 market close

Performance

1 Month
-18.6%
3 Months
-35.2%
YTD
-52.2%
1 Year
-31.2%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
78.4%
Largest decline max drawdown, since Aug 2025
-68.0%
Risk-adjusted return Sharpe ratio, 1-year
-0.08

Own EBS?

See how EBS contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.